Molecular-phenotypic correlations for 26 italian subjects with androgen insensitivity due to mutations in the androgen receptors gene
Paolo Ghirri(University of Pisa), T. R. Brown(Johns Hopkins University), Ana S.A. Cohen(Children's Mercy Hospital), Barbara Bardoni(Istituto di Genetica Molecolare), Lucia Ghizzoni(University of Parma), S. Bradford, Giovanna Camerino(University of Sassari), Daniela Larizza, Giuseppe Saggese(Ospedale Santa Chiara), Giuseppe Tonini(Campus Bio Medico University Hospital), Sergio Bernasconi(University of Parma), R Virdis(University of Parma), Paolo Simi(Ospedale Santa Chiara), Antonio Boldrini(University of Bergamo), R Balducci, C. Livieri(University of Pavia), Fulvia Baldinotti
CINECA IRIS Institutial research information system (University of Pisa)
January 1, 1997
Cited by 0
Related Papers
Endocrine-Disrupting Chemicals and Public Health Protection: A Statement of Principles from The Endocrine Society
|Endocrinology|2012|1.2k
FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study
|The Lancet Oncology|2015|1.1k
Initial Therapy with FOLFOXIRI and Bevacizumab for Metastatic Colorectal Cancer
|New England Journal of Medicine|2014|1.1k
A gene deleted in Kallmann's syndrome shares homology with neural cell adhesion and axonal path-finding molecules
|Nature|1991|851
R-spondin1 is essential in sex determination, skin differentiation and malignancy
|Nature Genetics|2006|773